Temporal trends and predictors of salvage cancer treatment after failure following radical prostatectomy or radiation therapy: An analysis from the CaPSURE registry

Cancer

Volumn 120, Issue 4, 2014, Pages 507-512

  Cary, K Clint ^a   Paciorek, Alan ^a   Fuldeore, Mahesh J ^b   Carroll, Peter R ^a   Cooperberg, Matthew R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ABBVIE INC   (United States)

Author keywords

outcomes research; prostate cancer; recurrence; salvage therapy; trends

Indexed keywords

OUTCOMES RESEARCH; PROSTATE CANCER; RECURRENCE; SALVAGE THERAPY; TRENDS;

AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 84893776646     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28446     Document Type: Article

References (27)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63: 11-30.
2. Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA. 2005; 294: 433-439. (Pubitemid 41124175)
3. Kuban DA, Thames HD, Levy LB, et al. Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys. 2003; 57: 915-928. (Pubitemid 37324109)
4. Khan MA, Han M, Partin AW, et al. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology. 2003; 62: 86-91. (Pubitemid 36802077)
5. Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA. 1999; 281: 1598-1604. (Pubitemid 29211768)
6. Agarwal PK, Sadetsky N, Konety BR, et al. Treatment failure after primary and salvage therapy for prostate cancer. Cancer. 2008; 112: 307-314.
7. Grossfeld GD, Stier DM, Flanders SC, et al. Use of second treatment following definitive local therapy for prostate cancer: data from the CaPSURE database. J Urol. 1998; 160: 1398-1404. (Pubitemid 29480525)
8. Lubeck DP, Litwin MS, Henning JM, et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology. 1996; 48: 773-777. (Pubitemid 26398700)
9. Cooperberg MR, Broering JM, Litwin MS, et al. The contemporary management of prostate cancer in the United States: lessons from the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE), A National Disease Registry. J Urol. 2004; 171: 1393-1401. (Pubitemid 38365382)
10. Cooperberg MR, Pasta DJ, Elkin EP, et al. The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy. J Urol. 2005; 173: 1938-1942. (Pubitemid 40675216)
11. Stephenson AJ, Scardino PT, Kattan MW, et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol. 2007; 25: 2035-2041. (Pubitemid 46972788)
12. Greene KL, Albertsen PC, Babaian RJ, et al. Prostate specific antigen best practice statement: 2009 update. J Urol. 2009; 182: 2232-2241.
13. Moreira DM, Bañez LL, Presti JC Jr, et al. Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database. BJU Int. 2009; 105: 28-33.
14. Mehta SS, Lubeck DP, Sadetsky N, Pasta DJ, Carrol,. Patterns of secondary cancer treatment for biochemical failure following radical prostatectomy: data from CaPSURE. J Urol. 2004; 171: 215-219. (Pubitemid 37549126)
15. Grossfeld GD, Li Y-P, Lubeck DP, et al. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol. 2002; 168: 530-535. (Pubitemid 34793288)
16. Saigal CS, Gore JL, Krupski TL, et al. Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer. 2007; 110: 1493-1500. (Pubitemid 47463063)
17. Punnen S, Cooperberg MR, Sadetsky N, et al. Androgen deprivation therapy and cardiovascular risk. J Clin Oncol. 2011; 29: 3510-3516.
18. Nguyen PL, Je Y, Schutz FAB, et al. Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA. 2011; 306: 2359-2366.
19. Goenka A, Magsanoc JM, Pei X, et al. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy. Eur Urol. 2011; 60: 1142-1148.
20. Kaffenberger SD, Keegan KA, Bansal NK, et al. Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience. J Urol. 2013; 189: 507-513.
21. Chade DC, Shariat SF, Cronin AM, et al. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol. 2011; 60: 205-210.
22. Lee B, Shinohara K, Weinberg V, et al. Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: the University of California-San Francisco experience. Int J Radiat Oncol Biol Phys. 2007; 67: 1106-1112.
23. Nguyen PL, Chen M-H, D'Amico AV, et al. Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: a prospective phase 2 study. Cancer. 2007; 110: 1485-1492. (Pubitemid 47463062)
24. Williams AK, Martínez CH, Lu C, et al. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer. Eur Urol. 2011; 60: 405-410.
25. Cooperberg MR, Broering JM, Carroll PR,. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst. 2009; 101: 878-887.
26. Chade DC, Eastham J, Graefen M, et al. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol. 2012; 61: 961-971.
27. Prasad SM, Gu X, Kowalczyk KJ, Lipsitz SR, Nguyen PL, Hu JC,. Morbidity and costs of salvage vs. primary radical prostatectomy in older men. Urol Oncol. 2012;doi: 10.1016/j.urolonc.2012.04.004.